mitomycin has been researched along with Hodgkin Disease in 8 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggest that t-ANLL patients are not sensitive to SCE induction by either MNNG or MMC." | 1.28 | Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemia. ( Karrison, T; Larson, RA; Le Beau, MM; Rowley, JD; Sagher, D; Schwartz, JL; Strauss, B; Weichselbaum, RR, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Natoli, A | 1 |
| Lüpertz, R | 1 |
| Merz, C | 1 |
| Müller, WW | 1 |
| Köhler, R | 1 |
| Krammer, PH | 1 |
| Li-Weber, M | 1 |
| SAMPEY, JR | 2 |
| TANIDA, T | 1 |
| HIBINO, S | 1 |
| ISHIBASHI, Y | 1 |
| MYHRE, K | 1 |
| FJAERLI, J | 1 |
| Schwartz, JL | 1 |
| Karrison, T | 1 |
| Le Beau, MM | 1 |
| Larson, RA | 1 |
| Sagher, D | 1 |
| Strauss, B | 1 |
| Rowley, JD | 1 |
| Weichselbaum, RR | 1 |
1 review available for mitomycin and Hodgkin Disease
| Article | Year |
|---|---|
NEW AND OLD DRUGS IN THE MANAGEMENT OF HODGKIN'S DISEASE.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antineoplastic Agents; | 1964 |
7 other studies available for mitomycin and Hodgkin Disease
| Article | Year |
|---|---|
Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Cell Line, | 2013 |
Antibiotics in the control of Hodgkin's disease and the leukemias.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Azaserine; Dactinomycin; Hodgkin Disease; Humans | 1962 |
[HISTOPATHOLOGICAL EFFECTS OF ANTINEOPLASTIC AGENTS ON MALIGNANT LYMPHOMA].
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Geriatrics; Hodgkin Dise | 1964 |
CHEMOTHERAPY OF LEUKEMIA AND ALLIED DISEASES, WITH SPECIAL REFERENCE TO MYTOMYCIN C.
Topics: Blood; Bone Marrow; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid; Mitomycin; Neoplasms | 1964 |
CANCER CHEMOTHERAPY (MITOMYCIN-C) FOLLOWED BY BONE MARROW TRANSPLANTATION.
Topics: Bone Marrow Transplantation; Breast Neoplasms; Carcinoid Tumor; Carcinoma, Bronchogenic; Choriocarci | 1964 |
TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS.
Topics: Biomedical Research; Breast Neoplasms; Colonic Neoplasms; Drug Therapy; Esophageal Neoplasms; Female | 1964 |
Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemia.
Topics: Antineoplastic Agents; DNA Replication; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphocyt | 1989 |